A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors

Clinical trial NCT04577963 · TERMINATED

Trial details

NCT number: NCT04577963
Sponsor: Hutchmed
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Endometrial Cancer Solid Tumor, Unspecified, Adult Colorectal Cancer

Start date: 2021-08-09
Primary completion: 2024-06-18
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.